文献速递免疫规划传染病防控与疫情报告

孟加拉国国家引入十价肺炎球菌结合疫苗对侵袭性肺炎球菌疾病的影响:病例对照与时间趋势研究

Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies.
PubMed 文献 · Vaccine · 2021-08-28

该研究评估孟加拉国2015年3月将PCV10纳入国家免疫规划后对3-35月龄儿童侵袭性肺炎球菌病(IPD)的效果,采用社区队列随访、病例对照和时间趋势分析。结果显示,社区对照的匹配病例对照分析疫苗有效性为83%(95%CI:1.57-97.1%),门诊对照为90%(95%CI:-26.0%至99.1%),时间趋势分析估计疫苗有效性为80.1%(95%CI:38.4-93.6%)。结论认为PCV10在该儿童人群中预防IPD高度有效。

要点

  • PCV10纳入国家免疫规划后,孟加拉国儿童IPD发病率显著下降。
  • 匹配病例对照分析显示疫苗有效性83%-90%,时间趋势分析为80.1%。
  • 该研究为PCV10在低收入国家的真实世界效果提供了证据支持。

核心结论

  • PCV10在孟加拉国3-35月龄儿童中预防IPD高度有效。

研究设计与样本

  • 研究于2014年1月至2018年6月在孟加拉国锡尔赫特三个农村次区开展,每两个月随访3-35月龄儿童收集发病和就医数据。
  • 对因肺炎、脑膜炎或脓毒症就诊的儿童采集血液和脑脊液,用培养和分子检测分离肺炎球菌。
  • 年龄符合接种PCV且分离出肺炎球菌的儿童为病例,每个病例匹配4名年龄和性别匹配的门诊和社区对照。
  • 利用疫苗覆盖调查估计PCV覆盖率,进行病例对照和发病率趋势分析。

主要发现

  • 社区队列共获得217,605儿童年观察和154,773次病童就诊。
  • 从44名年龄符合接种PCV的儿童中分离出肺炎球菌并作为病例,匹配166名社区对照和150名门诊对照。
  • 社区对照的匹配病例对照分析显示疫苗有效性83%(95%CI:1.57-97.1%)。
  • 门诊对照的匹配病例对照分析显示疫苗有效性90%(95%CI:-26.0%至99.1%)。
  • 发病率趋势分析估计疫苗有效性80.1%(95%CI:38.4-93.6%)。

临床怎么用

  • 支持在类似低收入国家将PCV10纳入国家免疫规划以预防儿童IPD。
  • 真实世界证据可增强对PCV10接种后人群保护的信心。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Bangladesh introduced the ten-valent pneumococcal conjugate vaccine (PCV10) into its national immunization program in March 2015 creating an opportunity to assess the real-world impact of PCV on invasive pneumococcal disease (IPD). METHODS: Between January 2014 and June 2018, children aged 3-35 months in three rural sub-districts of Sylhet district of Bangladesh were visited every two months to collect morbidity and care-seeking data. Children attending sub-district hospitals with pneumonia, meningitis, or sepsis were assessed for IPD after obtaining informed consent. Blood and cerebrospinal fluid were collected from enrolled children to isolate pneumococcus using culture and molecular test. Children who were age-eligible to receive the PCV and had pneumococcus isolated were enrolled as cases. Four age and sex-matched clinic and community controls were selected for each case within one to two weeks of case identification. Data on immunization status and confounders were collected. PCV coverage was estimated using vaccine coverage surveys. Case-control and incidence trend analyses were conducted to assess the impact of PCV on IPD. RESULTS: The community cohort yielded 217,605 child years of observations and 154,773 sick child-visits to study hospitals. Pneumococcus was isolated from 44 children who were age-eligible to receive PCV; these children were enrolled as cases. The cases were matched with 166 community- and 150 clinic-controls. The matched case-control analyses using community-controls showed 83% effectiveness (95% CI: 1.57-97.1%) and clinic controls showed 90% effectiveness (95% CI: -26.0% to 99.1%) of PCV in preventing IPD. Incidence trend analysis estimated vaccine effectiveness at 80.1% (95% CI: 38.4, 93.6). CONCLUSION: PCV in this pediatric population in Bangladesh was highly effective in preventing IPD.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Baqui AH, Koffi AK, McCollum ED, et al. Impact of national introduction of ten-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in Bangladesh: Case-control and time-trend studies. Vaccine. 2021. PMID: 34465471. doi:10.1016/j.vaccine.2021.08.068

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。